A phase I study of Docetaxel (D) and Oxaliplatin (L-OHP) as front-line treatment in metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC)
Agelaki, S, Kouroussis, Ch, Mavroudis, D, Kalbakis, K, Souglakos, J, Reppa, D, Isbarach, I, Mixaki, I, Georgoulias, VVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80137-3
Date:
September, 2000
File:
PDF, 114 KB
english, 2000